Dr. Sowmya Ambuga Muralidhara, MD

Dr. Muralidhara practices at Sharp Grossmont Hospital in La Mesa, California, part of Sharp HealthCare.

Dr. Muralidhara's NPI, 1851533285, was assigned on March 31, 2009. Dr. Muralidhara graduated from J.J.M. Medical College in 2006. Dr. Muralidhara holds California license A114660.

Dr. Muralidhara's primary practice is Sharp Grossmont Hospital, at 5555 Grossmont Center Drive Box 58, La Mesa, CA 91942 in San Diego County. The practice phone is (619) 465-0711.

Dr. Muralidhara's primary practice is Sharp Grossmont Hospital in La Mesa, California, part of Sharp HealthCare. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Muralidhara to 2 more skilled nursing facilities, 2 medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Muralidhara practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Muralidhara's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Muralidhara is board certified in internal medicine by the American Board of Internal Medicine. Dr. Muralidhara is licensed in California.

Dmand AI lists acute respiratory failure, cardiac arrhythmia, chest pain, circulatory problems in extremities, cirrhosis, collapsed lung, congestive heart failure and electrolyte disorders among the conditions Dr. Muralidhara treats.

CMS data shows 941 Medicare services from Dr. Muralidhara across 4 procedure codes in 2024, for 223 Medicare patients. Medicare paid $95,648 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 223 Medicare patients who saw Dr. Muralidhara in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 53% are also on Medicaid. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Muralidhara's median patient age at 68, with 51% women.

In 2024, Dr. Muralidhara wrote 471 Medicare Part D claims for 208 patients. 86% of them were for generic drugs. CMS names the drug for 202 of them, across 11 drugs with 11 or more claims each, at $1,462 in total drug cost. In 2023, CMS named 166 claims across 8 drugs.

Dr. Muralidhara accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 34 general payments to Dr. Muralidhara from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $157.

Dr. Muralidhara graduated from J.J.M. Medical College in 2006.

Dr. Muralidhara is in network with 5 carriers, including Blue Cross Blue Shield of Massachusetts, Blue Cross Blue Shield of Michigan and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.